GeneDx Holdings (WGS) Other Non-Current Liabilities (2020 - 2026)

GeneDx Holdings (WGS) has reported Other Non-Current Liabilities for 7 consecutive years, with $71000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 98.93% year-over-year to $71000.0; the TTM figure through Mar 2026 stood at $71000.0 (down 98.93% YoY), while the FY2025 annual figure was $1.6 million, down 70.27% from the prior year.
• Other Non-Current Liabilities fell to $71000.0 in Q1 2026 per WGS's latest filing, from $1.6 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $24.0 million in Q4 2022 and bottomed at $71000.0 in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $11.7 million across 5 years, with a median of $12.7 million in 2024.
• Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 4382.2% — and 2026, when it sank 98.93%.
• GeneDx Holdings' Other Non-Current Liabilities stood at $24.0 million in 2022, then sank by 38.65% to $14.7 million in 2023, then tumbled by 62.54% to $5.5 million in 2024, then plunged by 70.27% to $1.6 million in 2025, then tumbled by 95.67% to $71000.0 in 2026.
• Business Quant data shows WGS's Other Non-Current Liabilities at $71000.0 in Q1 2026, $1.6 million in Q4 2025, and $4.3 million in Q3 2025.